Classical Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Classical Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers [Phase 1]
Phase 1 clinical trial update for PF-08046032 in people with advanced cancers; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment [Phase 2, Phase 3]
A multinational Phase 2/3 trial is studying Brentuximab Vedotin as initial therapy for newly diagnosed classical Hodgkin lymphoma in Chinese…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Phase 2 trial update evaluating the combination of ibrutinib and nivolumab for relapsed or refractory classical Hodgkin lymphoma, sponsored …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating A(B)VD chemotherapy followed by Nivolumab as frontline therapy for higher-risk classical Hodgkin lymph…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma
This trial is investigating the use of circulating tumor DNA as a non-invasive biomarker to monitor therapy in pediatric classical Hodgkin l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
MacroGenics reports a Phase 1 study of MGD024 in relapsed or refractory hematologic malignancies is currently recruiting across multiple dis…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant. [Phase 2]
A Phase 2 clinical trial evaluating chidamide and decitabine in combination with an anti-PD-1 antibody for relapsed/refractory classical Hod…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of brentuximab vedotin and nivolumab for relapsed/refractory classical Hodgkin lymphoma;…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors [Phase 2]
Phase 2 clinical trial investigating the combination of Brentuximab Vedotin and Nivolumab for relapsed/refractory classical Hodgkin lymphoma…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas [Phase 1]
Phase 1 clinical trial evaluating allogeneic CD30.CAR-EBVSTs in relapsed or refractory CD30-positive lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma [Phase 2]
A Phase 2 study evaluating pembrolizumab followed by chemotherapy for classical Hodgkin lymphoma is described. The trial is currently active…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
This clinical trial aims to change paradigms in the prognostic assessment of classical Hodgkin lymphoma and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma [Phase 2]
Phase II trial evaluating an anti-PD-1 antibody in combination with radiotherapy for early-stage favorable Classical Hodgkin Lymphoma; the s…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating magrolimab in combination with pembrolizumab for relapsed or refractory classical Hodgkin lymphoma. The st…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study [Phase 2]
Phase II clinical trial evaluating the combination of sintilimab with AVD (doxorubicin, vinblastine, and dacarbazine) in pediatric patients …
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab in combination with salvage chemotherapy for first-relapsed or refractory classical Hodgkin …
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating pianzumab in combination with the AVD chemotherapy regimen for newly diagnosed advanced classical Hod…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Chidamide+Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant. [Phase 2]
A Phase 2 clinical trial evaluating chidamide plus decitabine and an anti-PD-1 antibody in patients with relapsed/refractory classical Hodgk…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma [Phase 2]
Phase II clinical trial investigating individualized immunotherapy for early-stage unfavorable classical Hodgkin lymphoma is currently recru…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above [Phase 2]
This clinical trial update describes a Phase 2 study of a fitness-adapted, pembrolizumab-based regimen for untreated classical Hodgkin lymph…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma [Phase 3]
Phase 3 trial evaluating IMM01 plus Tiselizumab versus physician's choice chemotherapy in PD-L1-refractory classical Hodgkin lymphoma; study…
-
CLINICAL_TRIALS research · 2021-06-25Clinical Trial Update: B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes
A completed retrospective study assessing treatment practices and outcomes in classical Hodgkin lymphoma, including relapsed or refractory c…
-
CLINICAL_TRIALS research · 2010-11-25Clinical Trial Update: The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy
A completed population-based study from Northern Italy evaluating how FDG-PET imaging is used in patients with Classical Hodgkin lymphoma.